R Trouette
Overview
Explore the profile of R Trouette including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
22
Citations
42
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Mollier O, Dupin C, Marnat G, Benech J, Vendrely V, Giraud N, et al.
Cancer Radiother
. 2022 Aug;
26(6-7):779-783.
PMID: 36030190
Stereotactic radiotherapy and radiosurgery allow delivery of high irradiation doses in a limited volume. These techniques are specially adapted to brain and nervous pathologies. Indication are not only cancers and...
2.
Pouypoudat C, Trouette R, Bernard B, Vendrely V
Cancer Radiother
. 2021 Aug;
25(6-7):523-525.
PMID: 34454836
Stereotactic radiotherapy is used for patients with oligometastases from colorectal cancer. It results in good local tumour control, especially for hepatic and pulmonary metastases, subject to a sufficiently high biologically...
3.
Haaser T, Berdai D, Trouette R, Dupin C, Marty S, LAzou B, et al.
Cancer Radiother
. 2020 Jun;
24(4):306-315.
PMID: 32499188
French regulations about research ethics are based on the so-called Jardé law, which defines researches involving human beings. Researches involving human beings require the submission of research protocols to a...
4.
Giraud N, Abdiche S, Trouette R
Cancer Radiother
. 2019 May;
23(4):346-354.
PMID: 31130373
While the prognosis of metastatic non-small-cell lung cancer has shown significant progress these last years, notably with the discovery of oncogen-driven subtypes and the development of targeted therapies, significant improvements...
5.
Dupin C, Arsene-Henry A, Charleux T, Haaser T, Trouette R, Vendrely V
Cancer Radiother
. 2018 Sep;
22(6-7):682-687.
PMID: 30197027
Purpose: Alternative and complementary medicine is defined as any substance or technique of non-allopathic medicine used to improve health and quality of life. The purpose of this prospective observational study...
6.
Bibault J, Arsene-Henry A, Durdux C, Mornex F, Hamza S, Trouette R, et al.
Cancer Radiother
. 2015 Sep;
19(6-7):458-62.
PMID: 26337476
Anatomical changes and tumor regression during thoracic radiotherapy may alter the treatment volumes. These modifications are not taken into account into set-up or motion margins used for treatment planning. Their...
7.
Huchet A, Fernandez P, Allard M, Belkacemi Y, Maire J, Trouette R, et al.
Cancer Radiother
. 2009 Oct;
13(8):747-57.
PMID: 19854090
By allowing an earlier diagnosis and a more exhaustive assessment of extension of the disease, the tomography by emission of positrons (TEP) transforms the care of numerous cancers. At present,...
8.
Huchet A, Caudry M, Belkacemi Y, Trouette R, Vendrely V, Causse N, et al.
Cancer Radiother
. 2003 Oct;
7(5):353-62.
PMID: 14522356
The first part of our work has focused on the relationship between tumor volume and tumor control. Indeed, it is well known that the importance of irradiated volume could be...
9.
Huchet A, Caudry M, Belkacemi Y, Trouette R, Vendrely V, Causse N, et al.
Cancer Radiother
. 2003 Apr;
7(2):79-89.
PMID: 12719037
Volume is an important parameter of radiation therapy. Local control is inversely related to tumor size and the complication rate increases with the importance of the irradiated volume. Although the...
10.
Begueret H, Vergier B, Begueret J, Vernejoux J, Jougon J, Trouette R, et al.
Eur J Cancer
. 2002 Nov;
38(17):2325-30.
PMID: 12441270
High grade lung neuroendocrine carcinomas, like small and large cell neuroendocrine carcinomas, pose therapeutic problems. Most initially respond to chemotherapeutic agents, but early relapses are frequent and are resistant to...